Amit Chopde
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amit Chopde has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Shailesh Vinayak Shrikhande
Division of Gastrointestinal and Hepato-Pancreato-Biliary Surgery, Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra 400012, India
7 shared publications - Manish Suresh Bhandare
Gastrointestinal and Hepato-Pancreato-Biliary Services, Department of Surgical Oncology, Homi Bhabha National Institute, Tata Memorial Hospital, Parel, Mumbai, India
6 shared publications - Vikram Chaudhari
Division of GI and HPB Surgery, Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, India
4 shared publications - Anant Ramaswamy
Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, Maharashtra, India
3 shared publications - Kaival Gundavda
Hepatopancreatobiliary Division of Department of Surgical Oncology Tata Memorial Hospital Mumbai India
3 shared publications - Shraddha Patkar
Department of Surgical Oncology, Tata Memorial Hospital, Mumbai, India
3 shared publications
Latest Publications
- 3 April 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (4) , e70525
Expanding the Abdominal Domain: Long‐Term Success of the Vascularized Posterior Rectus Sheath–Liver Composite Allograft
Background: Achieving a tension‐free abdominal wall closure in liver transplantation (LT) is challenging, particularly in the presence of donor–recipient size mismatch, prior surgeries, or loss of abdominal domain. These difficulties are amplified when expanded‐criteria donor (ECD) grafts are used, as graft reduction is unsafe and prolonging cold ischemia time (CIT) is not feasible. A vascularized posterior rectus sheath (PRS) allograft, supplied via the hepatic falciform artery (HFA), offers physiological abdominal domain expansion without the infection risks associated with prosthetic meshes or non‐vascularized fascia. Methods: A retrospective review was conducted of all patients undergoing LT with a vascularized PRS allograft at our center. PRS retrieval and implantation were performed using a standardized technique. All patients received conventional immunosuppression. Recipient and donor characteristics, postoperative outcomes, and long‐term follow‐up were analyzed. Results: Five patients (four adults, one child) received a composite liver–PRS allograft. Median donor–recipient weight ratio was 1.7 (range: 1.46–2.18). All grafts met ECD criteria. Mean CIT and warm ischemia time were 4 ± 1.01 h and 43.6 ± 9.54 min, respectively. Primary fascial closure was achieved in all patients without graft infection, abdominal wall infection, or PRS necrosis. One patient developed a rectus sheath hematoma requiring drainage, and another developed a postoperative bulge requiring plication. Median long‐term follow‐up of 9.1 (range: 8.38–10.63) years demonstrated durable fascial integrity. Conclusion: The vascularized PRS allograft is a simple, reproducible, single‐stage solution for abdominal closure in LT, particularly valuable when using ECD grafts, minimizing infection risk, reexplorations, and prolonged CIT.
- 3 April 2026
- Published by Wiley in Clinical Transplantation
- Vol. 40 (4) , e70525
Expanding the Abdominal Domain: Long‐Term Success of the Vascularized Posterior Rectus Sheath–Liver Composite Allograft
Background: Achieving a tension‐free abdominal wall closure in liver transplantation (LT) is challenging, particularly in the presence of donor–recipient size mismatch, prior surgeries, or loss of abdominal domain. These difficulties are amplified when expanded‐criteria donor (ECD) grafts are used, as graft reduction is unsafe and prolonging cold ischemia time (CIT) is not feasible. A vascularized posterior rectus sheath (PRS) allograft, supplied via the hepatic falciform artery (HFA), offers physiological abdominal domain expansion without the infection risks associated with prosthetic meshes or non‐vascularized fascia. Methods: A retrospective review was conducted of all patients undergoing LT with a vascularized PRS allograft at our center. PRS retrieval and implantation were performed using a standardized technique. All patients received conventional immunosuppression. Recipient and donor characteristics, postoperative outcomes, and long‐term follow‐up were analyzed. Results: Five patients (four adults, one child) received a composite liver–PRS allograft. Median donor–recipient weight ratio was 1.7 (range: 1.46–2.18). All grafts met ECD criteria. Mean CIT and warm ischemia time were 4 ± 1.01 h and 43.6 ± 9.54 min, respectively. Primary fascial closure was achieved in all patients without graft infection, abdominal wall infection, or PRS necrosis. One patient developed a rectus sheath hematoma requiring drainage, and another developed a postoperative bulge requiring plication. Median long‐term follow‐up of 9.1 (range: 8.38–10.63) years demonstrated durable fascial integrity. Conclusion: The vascularized PRS allograft is a simple, reproducible, single‐stage solution for abdominal closure in LT, particularly valuable when using ECD grafts, minimizing infection risk, reexplorations, and prolonged CIT.
- 2 March 2026
- Published by Elsevier in Journal of Cancer Policy
- Vol. 48, 100730
Financial toxicity among gastric and pancreatic cancer survivors in India and its impact on quality of life
- 2 March 2026
- Published by Elsevier in Journal of Cancer Policy
- Vol. 48, 100730
Financial toxicity among gastric and pancreatic cancer survivors in India and its impact on quality of life
- 16 September 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (13) , 8764-8765
ASO Visual Abstract: Prognostic Impact of Para-aortic Lymph Node Metastasis in Resected Nonpancreatic Periampullary Cancers
- 16 September 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (13) , 8764-8765
ASO Visual Abstract: Prognostic Impact of Para-aortic Lymph Node Metastasis in Resected Nonpancreatic Periampullary Cancers
- Open Access
- 20 July 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (10) , 7052-7063
Prognostic Impact of Para-Aortic Lymph Node Metastasis in Resected Non-Pancreatic Periampullary Cancers
Background: Surgery remains debatable in para-aortic lymph node (PALN, station 16b1) metastasis in non-pancreatic periampullary cancer (NPPAC). This study examined the impact of PALN metastasis on outcomes following pancreaticoduodenectomy (PD) in NPPAC. Methods: A retrospective analysis of patients with NPPAC who were explored for PD with PALN dissection was performed. Based on the extent of nodal involvement on final histopathology, they were stratified as node-negative (N0), regional node involved (N+) and metastatic PALN (N16+) and their outcomes were compared. Results: Between 2011 and 2022, 153/887 PD patients underwent a PALN dissection, revealing N16+ in 42 patients (27.4%), of whom 32 patients underwent resection. The 3-years overall survival (OS) for patients with N16+ was 28% (95% confidence interval [CI] 13–60%), notably lower than the 67% (95% CI 53–83.5%; p = 0.007) for those without PALN metastasis. Stratified by nodal involvement, the median OS for N+ and N16+ patients was similar (28.4 months and 26.2 months, respectively). The N0 subgroup had a significantly longer 3-years OS of 87.5% (95% CI 79–96.7%; p = 0.0051). Interestingly, 10 patients not offered resection following N16+ identified on frozen section had a median survival of only 9 months. The perioperative morbidity and mortality in patients undergoing PD with PALN dissection were similar to standard resections. Conclusion: In a select group of patients with NPPAC, PD in isolated PALN metastasis was associated with improved OS. The survival in this group of patients was comparable with regional node-positive patients and significantly better than palliative treatment alone.
- 20 July 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (10) , 7052-7063
Open AccessPrognostic Impact of Para-Aortic Lymph Node Metastasis in Resected Non-Pancreatic Periampullary Cancers
Background: Surgery remains debatable in para-aortic lymph node (PALN, station 16b1) metastasis in non-pancreatic periampullary cancer (NPPAC). This study examined the impact of PALN metastasis on outcomes following pancreaticoduodenectomy (PD) in NPPAC. Methods: A retrospective analysis of patients with NPPAC who were explored for PD with PALN dissection was performed. Based on the extent of nodal involvement on final histopathology, they were stratified as node-negative (N0), regional node involved (N+) and metastatic PALN (N16+) and their outcomes were compared. Results: Between 2011 and 2022, 153/887 PD patients underwent a PALN dissection, revealing N16+ in 42 patients (27.4%), of whom 32 patients underwent resection. The 3-years overall survival (OS) for patients with N16+ was 28% (95% confidence interval [CI] 13–60%), notably lower than the 67% (95% CI 53–83.5%; p = 0.007) for those without PALN metastasis. Stratified by nodal involvement, the median OS for N+ and N16+ patients was similar (28.4 months and 26.2 months, respectively). The N0 subgroup had a significantly longer 3-years OS of 87.5% (95% CI 79–96.7%; p = 0.0051). Interestingly, 10 patients not offered resection following N16+ identified on frozen section had a median survival of only 9 months. The perioperative morbidity and mortality in patients undergoing PD with PALN dissection were similar to standard resections. Conclusion: In a select group of patients with NPPAC, PD in isolated PALN metastasis was associated with improved OS. The survival in this group of patients was comparable with regional node-positive patients and significantly better than palliative treatment alone.
- 16 April 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (6) , 108343
Impact of pCR after neoadjuvant chemotherapy and radical D2 dissection in locally advanced gastric cancers: Analysis of 1001 cases
- 16 April 2024
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (6) , 108343
Impact of pCR after neoadjuvant chemotherapy and radical D2 dissection in locally advanced gastric cancers: Analysis of 1001 cases
- Open Access
- 28 December 2023
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 28 (1) , 99-103
Gastric salvage after venous congestion during major pancreatic resections: A series of three cases
Ravi Chandra Reddy, Vikram Chaudhari, Amit Chopde, Abhishek Mitra, Dushyant Jaiswal, Shailesh V. Shrikhande, Manish S. Bhandare. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.23-089
- 28 December 2023
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 28 (1) , 99-103
Open AccessGastric salvage after venous congestion during major pancreatic resections: A series of three cases
Ravi Chandra Reddy, Vikram Chaudhari, Amit Chopde, Abhishek Mitra, Dushyant Jaiswal, Shailesh V. Shrikhande, Manish S. Bhandare. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.23-089
- 11 October 2023
- Published by Wiley in Journal of Surgical Oncology
- Vol. 128 (6) , 1003-1010
Big data and RCT's in surgical oncology: Impact on improving hepatopancreatobiliary cancer surgical care on the global stage
Randomized controlled clinical trials (RCTs) are at the heart of “evidence‐based” medicine. Conducting well‐designed RCTs for surgical procedures is often challenged by inadequate recruitment accrual, blinding, or standardization of the surgical procedure, as well as lack of funding and evolution of the treatment strategy during the many years over which such trials are conducted. In addition, most clinical trials are performed in academic high‐volume centers with highly selected patients, which may not necessarily reflect a “real‐world” practice setting. Large databases provide easy and inexpensive access to data on a large and diverse patient population at a variety of treatment centers. Furthermore, large database studies provide the opportunity to answer questions that would be impossible or very arduous to answer using RCTs, including questions regarding health policy efficacy, trends in surgical practice, access to health care, the impact of hospital volume, and adherence to practice guidelines, as well as research questions regarding rare disease, infrequent surgical outcomes, and specific subpopulations. Prospective data registries may also allow for quality benchmarking and auditing. There are several high‐quality RCTs providing evidence to support current practices in hepatopancreatobiliary (HPB) oncology. Evidence from big data bridges the gap in several instances where RCTs are lacking. In this article, we review the evidence from RCTs and big data in HPB oncology identify the existing lacunae, and discuss the future directions of research in HPB oncology.
- 11 October 2023
- Published by Wiley in Journal of Surgical Oncology
- Vol. 128 (6) , 1003-1010
Big data and RCT's in surgical oncology: Impact on improving hepatopancreatobiliary cancer surgical care on the global stage
Randomized controlled clinical trials (RCTs) are at the heart of “evidence‐based” medicine. Conducting well‐designed RCTs for surgical procedures is often challenged by inadequate recruitment accrual, blinding, or standardization of the surgical procedure, as well as lack of funding and evolution of the treatment strategy during the many years over which such trials are conducted. In addition, most clinical trials are performed in academic high‐volume centers with highly selected patients, which may not necessarily reflect a “real‐world” practice setting. Large databases provide easy and inexpensive access to data on a large and diverse patient population at a variety of treatment centers. Furthermore, large database studies provide the opportunity to answer questions that would be impossible or very arduous to answer using RCTs, including questions regarding health policy efficacy, trends in surgical practice, access to health care, the impact of hospital volume, and adherence to practice guidelines, as well as research questions regarding rare disease, infrequent surgical outcomes, and specific subpopulations. Prospective data registries may also allow for quality benchmarking and auditing. There are several high‐quality RCTs providing evidence to support current practices in hepatopancreatobiliary (HPB) oncology. Evidence from big data bridges the gap in several instances where RCTs are lacking. In this article, we review the evidence from RCTs and big data in HPB oncology identify the existing lacunae, and discuss the future directions of research in HPB oncology.
- Open Access
- 29 September 2021
- Published by Springer Nature in Research Square
Neuroendocrine Tumours of Extrahepatic Biliary Tract: Series of Four Cases with Literature Review
Neuroendocrine tumours (NETs) originating from extrahepatic bile duct are an extremely rare entity. They are typically slow growing tumours with malignant potential. Commonly presenting as obstructive jaundice, preoperative clinico-radiologic differentiation between extrahepatic biliary tract neuroendocrine tumours and cholangiocarcinoma is difficult and the final diagnosis is usually established after surgical histopathology and immunohistochemistry examination. R0 resection offers the only curative option with good long term outcomes for Well differentiated NETs (grade1, grade2 and grade3) whilst the aggressive poorly differentiated Neuroendocrine Carcinoma (NEC) needs multimodality approach. We present our experience of management of four cases including three cases of grade II NET and one case of NEC undergoing surgical resection at a single centre with a short review of available literature.
- 29 September 2021
- Published by Springer Nature in Research Square
Open AccessNeuroendocrine Tumours of Extrahepatic Biliary Tract: Series of Four Cases with Literature Review
Neuroendocrine tumours (NETs) originating from extrahepatic bile duct are an extremely rare entity. They are typically slow growing tumours with malignant potential. Commonly presenting as obstructive jaundice, preoperative clinico-radiologic differentiation between extrahepatic biliary tract neuroendocrine tumours and cholangiocarcinoma is difficult and the final diagnosis is usually established after surgical histopathology and immunohistochemistry examination. R0 resection offers the only curative option with good long term outcomes for Well differentiated NETs (grade1, grade2 and grade3) whilst the aggressive poorly differentiated Neuroendocrine Carcinoma (NEC) needs multimodality approach. We present our experience of management of four cases including three cases of grade II NET and one case of NEC undergoing surgical resection at a single centre with a short review of available literature.
- 27 April 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (5) , 2029-2038
SMA syndrome: management perspective with laparoscopic duodenojejunostomy and long-term results
Background Superior mesentery artery syndrome (SMAS) is a rare vasculo-anatomic occlusive pathologic entity for which a period of conservative medical management is advocated with surgery reserved for nonresponsive cases. We present our management plan that entails a single admission approach and complete rendering of medical and surgical treatment to the patient on a background of the socioeconomic and cultural trends prevalent in this geographic region. Methods A retrospective analysis of 22 cases of SMAS admitted in our health care system who underwent a period of preoperative conditioning followed by laparoscopic duodenojejunostomy from September 2009 to June 2019 was performed. Patients were followed up at regular intervals. Results The mean follow-up of the cohort was 41.2 months (2–108 months). The median length of stay was 6 days. The mean postoperative stay was 4.13 days. A subgroup of six patients who had severe physiological depletion required a period of preoperative optimisation. Five of the 22 (22.7%) patients suffered from postoperative complications in the form of delayed return of bowel functions. None of the patients had complications more than Clavien–Dindo grade 2 with no mortality. Long-term data are available for 19 patients (86.3%) which showed no symptom recurrence. Conclusion Management of SMAS that entails an antecedent medical therapy followed by surgery can be accomplished in a single admission with good to excellent results in the intermediate and long-term follow-up. Physiologically depleted patients do require a period of intensive preconditioning but on long-term follow-up, they have excellent results.
- 27 April 2020
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (5) , 2029-2038
SMA syndrome: management perspective with laparoscopic duodenojejunostomy and long-term results
Background Superior mesentery artery syndrome (SMAS) is a rare vasculo-anatomic occlusive pathologic entity for which a period of conservative medical management is advocated with surgery reserved for nonresponsive cases. We present our management plan that entails a single admission approach and complete rendering of medical and surgical treatment to the patient on a background of the socioeconomic and cultural trends prevalent in this geographic region. Methods A retrospective analysis of 22 cases of SMAS admitted in our health care system who underwent a period of preoperative conditioning followed by laparoscopic duodenojejunostomy from September 2009 to June 2019 was performed. Patients were followed up at regular intervals. Results The mean follow-up of the cohort was 41.2 months (2–108 months). The median length of stay was 6 days. The mean postoperative stay was 4.13 days. A subgroup of six patients who had severe physiological depletion required a period of preoperative optimisation. Five of the 22 (22.7%) patients suffered from postoperative complications in the form of delayed return of bowel functions. None of the patients had complications more than Clavien–Dindo grade 2 with no mortality. Long-term data are available for 19 patients (86.3%) which showed no symptom recurrence. Conclusion Management of SMAS that entails an antecedent medical therapy followed by surgery can be accomplished in a single admission with good to excellent results in the intermediate and long-term follow-up. Physiologically depleted patients do require a period of intensive preconditioning but on long-term follow-up, they have excellent results.